Sugi Predict

Sugi Predict / Compounds / SCHEMBL20945158

SCHEMBL20945158

SCHEMBL20945158

CC(O)(CNC(=O)OC(C)(C)C)Cn1cccc(N)c1=O

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ELANE P08246 1/20 0.39
▸ MALT1 Q9UDY8 1/20 0.37
▸ PCSK9 Q8NBP7 1/20 0.35
▸ HDAC1 Q13547 1/20 0.35
▸ EPHX2 P34913 1/20 0.34
▸ KDM4A O75164 1/20 0.34
▸ SYK P43405 1/20 0.34
▸ SIGMAR1 Q99720 2/20 0.34
▸ LATS1 O95835 1/20 0.34
▸ LATS2 Q9NRM7 1/20 0.34
▸ CA1 P00915 3/20 0.33
▸ CA2 P00918 3/20 0.33
▸ CA12 O43570 2/20 0.33
▸ CA9 Q16790 2/20 0.33
▸ CKS1B P61024 1/20 0.33
▸ SKP1 P63208 1/20 0.33
▸ SKP2 Q13309 1/20 0.33
▸ DDB1 Q16531 1/20 0.33
▸ CRBN Q96SW2 1/20 0.33
▸ AAK1 Q2M2I8 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20944926 0.82 ELANE (0.43) ELANEMALT1
SCHEMBL20945124 0.81 DRD2 (0.44) ELANEMALT1SIGMAR1CA1CA2
SCHEMBL5116947 0.77 ELANE (0.48) ELANE
SCHEMBL20945015 0.73 ELANE (0.44) ELANEHDAC1
SCHEMBL25938297 0.72 ELANE (0.43) ELANEHDAC1KDM4ACA1CA2
SCHEMBL21924470 0.71 ELANE (0.38) ELANE
SCHEMBL8649103 0.69 ELANE (0.51) ELANE
SCHEMBL4565908 0.69 HDAC1 (0.50) MALT1HDAC1KDM4ASYKSIGMAR1
Hydrochloric Acid SCHEMBL20944983 0.68 ELANE (0.50) ELANE
SCHEMBL21389406 0.68 DRD2 (0.45) MALT1SIGMAR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-109415345-B Pyridazinone-based broad-spectrum anti-influenza inhibitors 豪夫迈·罗氏有限公司 2022-01-11 — — CN disclosed
EP-3478671-B1 PYRIDAZINONE-BASED BROAD SPECTRUM ANTI-INFLUENZA INHIBITORS HOFFMANN LA ROCHE (CH) 2020-05-13 — — EP disclosed
EP-3478671-B1 PYRIDAZINONE-BASED BROAD SPECTRUM ANTI-INFLUENZA INHIBITORS HOFFMANN LA ROCHE (CH) 2020-05-13 — — EP disclosed
US-10597380-B2 Pyridazinone-based broad spectrum anti-influenza inhibitors HOFFMANN-LA ROCHE INC. (US) 2020-03-24 — — US disclosed
US-10597380-B2 Pyridazinone-based broad spectrum anti-influenza inhibitors HOFFMANN-LA ROCHE INC. (US) 2020-03-24 — — US disclosed
US-20190127349-A1 PYRIDAZINONE-BASED BROAD SPECTRUM ANTI-INFLUENZA INHIBITORS HOFFMANN-LA ROCHE INC. (US) 2019-05-02 — — US disclosed
US-20190127349-A1 PYRIDAZINONE-BASED BROAD SPECTRUM ANTI-INFLUENZA INHIBITORS HOFFMANN-LA ROCHE INC. (US) 2019-05-02 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20190127349-A1 PYRIDAZINONE-BASED BROAD SPECTRUM ANTI-INFLUENZA INHIBITORS ABCG2, PIR, PRNP ELANE 2561/4885MALT1 4805/4885PCSK9 2240/4885
US-10597380-B2 Pyridazinone-based broad spectrum anti-influenza inhibitors ABCG2, PIR, PRNP ELANE 2561/4885MALT1 4805/4885PCSK9 2240/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.